World's Best Scientists 2026 revealed!
Kenneth K. Tanabe

Kenneth K. Tanabe

D-Index & Metrics

Medicine

D-Index
93
Citations
28909
World Ranking
10968
National Ranking
5640

Overview

Kenneth K. Tanabe is affiliated with Harvard University in the United States. The main field of study is Medicine, with a significant focus on Oncology, Hepatology, Epidemiology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging. The researcher's work spans several critical areas in medical science, particularly related to liver diseases, cancer, and their treatment and diagnosis.

The scientist's recent publications include notable papers such as:

  • Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma, 2020, published in Gut
  • The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines, 2021, Annals of Surgical Oncology
  • Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons, 2020, Annals of Surgery
  • Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patients, 2023, Nature Biomedical Engineering
  • An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS), 2022, Annals of Surgery

The main topics of work addressed by Kenneth K. Tanabe include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pancreatic and Hepatic Oncology Research
  • Liver physiology and pathology
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer, Hypoxia, and Metabolism
  • Liver Disease and Transplantation

Frequent co-authors in research collaborations are:

  • Mozhdeh Sojoodi
  • Motaz Qadan
  • Peter Caravan
  • Bryan C. Fuchs
  • Michael Lanuti

Research outputs have appeared repeatedly in prominent publication venues including:

  • Cancer Research
  • Annals of Surgical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Hepatology
  • Annals of Surgery

Best Publications

  • Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

    R Soiffer;T Lynch;M Mihm;K Jung

  • Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

    Darrell R. Borger;Kenneth K. Tanabe;Kenneth C. Fan;Hector U. Lopez

  • Treatment of intrahepatic malignancy with radiofrequency ablation:radiologic-pathologic correlation

    S. Nahum Goldberg;G. Scott Gazelle M.D.;Carolyn C. Compton M.D.;Peter R. Mueller

  • Percutaneous Radiofrequency Tissue Ablation: Does Perfusion-mediated Tissue Cooling Limit Coagulation Necrosis?

    S. Nahum Goldberg;Peter F. Hahn;Kenneth K. Tanabe;Peter R. Mueller

  • Role of the unfolded protein response in cell death.

    R. Kim;M. Emi;K. Tanabe;S. Murakami

  • Minimal-access surgery for staging of malignant melanoma.

    David N. Krag;Sybren J. Meijer;Sybren J. Meijer;Donald L. Weaver;Brian W. Loggie

  • Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

    Theodore S. Hong;Jennifer Y. Wo;Beow Y. Yeap;Edgar Ben-Josef

  • Cutaneous melanoma, version 2.2019

    Daniel G. Coit;John A. Thompson;Mark R. Albertini;Christopher Barker

  • Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma

    Robert Soiffer;F Stephen Hodi;Frank Haluska;Ken Jung

  • Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

    Bryan C. Fuchs;Tsutomu Fujii;Jon D. Dorfman;Jonathan M. Goodwin

  • Ablation of liver tumors using percutaneous RF therapy.

    S N Goldberg;G S Gazelle;L Solbiati;T Livraghi

  • Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

    K. K. Tanabe;Lee M Ellis;Hideyuki Saya

  • Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

    Laura Rubbia-Brandt;Gregory Y. Lauwers;Huamin Wang;Pietro E Majno

  • Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.

    Bryan C. Fuchs;Yujin Hoshida;Tsutomu Fujii;Lan Wei

  • Prognosis and Survival in Patients With Gastrointestinal Tract Carcinoid Tumors

    Khaled O. Shebani;Wiley W. Souba;Dianne M. Finkelstein;Paul C. Stark

  • Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma

    Derek J Erstad;Kenneth K Tanabe

  • Surgical management of phyllodes tumors.

    Abeel A. Mangi;Barbara L. Smith;Michele A. Gadd;Kenneth K. Tanabe

  • TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

    Lipika Goyal;Lei Shi;Leah Y Liu;Ferran Fece de la Cruz

  • Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma

    James S.V. Lally;Sarani Ghoshal;Danielle K. DePeralta;Omeed Moaven

  • Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas.

    Kenneth K. Tanabe;Raphael E. Pollock M.D.;Lee M. Ellis;B A Anne Murphy

Frequent Co-Authors

Cristina R. Ferrone
Cristina R. Ferrone Harvard University
Peter Caravan
Peter Caravan Harvard University
Gregory Y. Lauwers
Gregory Y. Lauwers Harvard University
Andrew X. Zhu
Andrew X. Zhu Harvard University
Arthur J. Sober
Arthur J. Sober Harvard University
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
Keith D. Lillemoe
Keith D. Lillemoe Harvard University
David P. Ryan
David P. Ryan Harvard University
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Timothy M. Pawlik
Timothy M. Pawlik The Ohio State University Wexner Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and supplementary career pathways can help you enter the medical field more quickly or affordably. For example, those interested in nursing may benefit from a 9 month lpn program, which allows you to become a Licensed Practical Nurse in less than a year and begin working while gaining valuable clinical experience.

Nurses who seek to advance their education might consider affordable dnp programs to become a Doctor of Nursing Practice without excessive debt. There are also options for quick specialization, such as the fastest psych np program for those interested in psychiatric and mental health careers.

Beyond clinical roles, healthcare administration is a growing field for those interested in leadership or operational positions within healthcare. If cost is a concern, research the healthcare administration degree cost to find budget-friendly programs.

These pathways can make healthcare careers more accessible, helping you tailor your education to your budget, timeline, and interests.

Best Scientists Citing Kenneth K. Tanabe

Trending Scientists

Recently Published Articles